Journal: bioRxiv
Article Title: VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
doi: 10.1101/2025.10.23.684214
Figure Lengend Snippet: ( a ) Volcano plot showing enrichment of VPS13C, OSBP and various lysosomal damage markers on lysosomes affinity-purified from HeLa cells treated with LLOMe (500 μM, 30 min). Green , proteins enriched in both intact (–LLOMe) and damaged (+LLOMe) lysosomes; blue , proteins selectively enriched in intact lysosomes; magenta , proteins selectively enriched in damaged lysosomes. ( b ) Whole cell lysates (WC) and lysosomes purified from untreated and LLOMe-treated HeLa cells (500 μM, 30 min) were subjected to immunoblot analysis using antibodies against VPS13C, OSBP, LAMP1, PI4K2A, hIST1, Gal3/LEG3 and p62/SQSTM. ( c ) Quantification of the data in (b). Bars show normalized values relative to control. Data are means ± SD. n = 4 biological replicates. ( d ) Time-lapse fluorescence images of U2OS wildtype (WT) and PI4K2A-KO cells expressing VPS13C-mClover or OSBP-GFP ( green ) that were fed CF633-labelled 70kDa dextran ( magenta ) and treated with 1 mM LLOMe for the indicated time. Cells were imaged by spinning disk microscopy. Scale bar, 5 µm. ( e ) Time-course plotting VPS13C- and OSBP-positive puncta per 100 μm area in cells treated as in (d). Data are means ± SD (VPS13C: n = 31 cells for WT, 29 cells for PI4K2A-KO; OSBP: n = 35 cells for WT, 33 cells for PI4K2A-KO) from 2 independent experiments.
Article Snippet: Chemical reagents were used at the following concentrations, unless indicated otherwise: 1 mM L-leucyl-L-leucine O-methyl ester (LLOMe; Bachem, 4000725), 200 μM glycyl-L-phenylalanine 2-naphtylamide (GPN; Abcam, ab145914), 75 nM LysoTracker TM Red DND-99 (Thermo Fisher Scientific; L7528), 200 nM Apilimod (Sigma-Aldrich, SML2974), 1.7 μM CF®633 dextran 70,000 MW (Biotium, 80141), 100 μg/ml 3 μm Polybead® Amino Microspheres (Polysciences Inc., 17145-5), 100 mM pHrodo TM Red Succinimidylester (ThermoFisher, P36600) and 100 nM BDP-FL-DBCO (Broadpharm, BP-23473).
Techniques: Affinity Purification, Purification, Western Blot, Control, Fluorescence, Expressing, Microscopy